G. Kees Hovingh

Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes

A. Michael Lincoff, Kirstine Brown‐Frandsen, Helen M. Colhoun et al. · New England Journal of Medicine · 2023 · 2.1K citations · Full text

Semaglutide in Patients with Heart Failure with Preserved Ejection Fraction and Obesity

Mikhail Kosiborod, Steen Z. Abildstrøm, Barry A. Borlaug et al. · New England Journal of Medicine · 2023 · 1.2K citations · Full text

Homozygous familial hypercholesterolaemia: new insights and guidance for clinicians to improve detection and clinical management. A position paper from the Consensus Panel on Familial Hypercholesterolaemia of the European Atherosclerosis Society

Marina Cuchel, Éric Bruckert, Henry N. Ginsberg et al. · European Heart Journal · 2014 · 1K citations · Full text

Common variants associated with plasma triglycerides and risk for coronary artery disease

Ron Do, Cristen J. Willer, Ellen M. Schmidt et al. · Nature Genetics · 2013 · 890 citations · Full text

Metabolic Syndrome, Cardiovascular Epidemiology, Cardiovascular Disease +11

PCSK9 inhibition with evolocumab (AMG 145) in heterozygous familial hypercholesterolaemia (RUTHERFORD-2): a randomised, double-blind, placebo-controlled trial

Frederick J. Raal, Evan A. Stein, Robert Dufour et al. · The Lancet · 2014 · 734 citations

Metabolic Syndrome, Lipid Disorder, Heterozygous Familial Hypercholesterolaemia +11